NCI | Technology Transfer

COMPOSITIONS AND METHODS FOR DETERMINING RESPONSIVENESS TO IMMUNE CHECKPOINT INHIBITORS (ICI), INCREASING EFFECTIVENESS OF ICI, AND TREATING CANCER

Read more about COMPOSITIONS AND METHODS FOR DETERMINING RESPONSIVENESS TO IMMUNE CHECKPOINT INHIBITORS (ICI), INCREASING EFFECTIVENESS OF ICI, AND TREATING CANCER

Patent Cooperation Treaty
PCT/US2022/032917
Filed on 2022-06-09

Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains

Read more about Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains

Spain
18759189.6
Filed on 2018-06-28

Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains

Read more about Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains

Germany
18759189.6
Filed on 2018-06-28

Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains

Read more about Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains

Italy
18759189.6
Filed on 2018-06-28

Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains

Read more about Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains

United Kingdom
18759189.6
Filed on 2018-06-28

Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains

Read more about Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains

France
18759189.6
Filed on 2018-06-28

PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY

Read more about PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY

US Application 17/783,866
Filed on 2022-06-09

PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY

Read more about PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY

China
202080086575.3
Filed on 2020-12-11

Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation

Read more about Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation

United Kingdom
14796317.7
Filed on 2014-10-02

Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation

Read more about Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation

Switzerland
14796317.7
Filed on 2014-10-02

Subscribe to NCI